| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥2592.0B | ¥2655.7B | -2.4% |
| Operating Income | ¥67.1B | ¥57.5B | +16.8% |
| Ordinary Income | ¥58.1B | ¥49.2B | +18.1% |
| Net Income | ¥55.2B | ¥81.3B | -32.1% |
| ROE | 4.1% | 6.2% | - |
FY2025 Q3 (9-month cumulative) results show revenue of 259.2B yen (YoY -2.4%) with operating income of 6.7B yen (+16.8%), ordinary income of 5.8B yen (+18.1%), and net income attributable to owners of 5.5B yen (-32.1%). The company achieved operating profit growth despite a minor revenue decline, driven by improved cost management and favorable product mix. However, net income declined significantly due to non-recurring gains in the prior period and changes in extraordinary items. Operating margin improved to 2.6% from 2.2% in the prior year, while the net profit margin declined to 2.1% from 3.1%. Total assets increased to 241.0B yen from 230.5B yen, with equity rising to 134.5B yen from 131.5B yen, maintaining a stable financial foundation.
Revenue declined 6.4B yen (-2.4%) to 259.2B yen, primarily driven by significant contraction in China sales which decreased from 85.8B yen to 66.3B yen (-22.7%). This 19.5B yen decline in China was partially offset by domestic Japan sales growth of 8.7B yen (+6.6%) from 132.4B yen to 141.1B yen, and modest Asia region expansion of 2.0B yen (+5.0%) from 40.3B yen to 42.4B yen. By business segment, the Device Business recorded sales of 187.0B yen (-3.4% YoY) while the Solution Business maintained relative stability at 72.2B yen (+0.4% YoY). The Device Business represents the core operation accounting for approximately 72% of total revenue. The geographic shift reflects strategic repositioning away from China market exposure toward stronger domestic penetration.
Operating income improved 9.6B yen (+16.8%) to 6.7B yen despite the revenue decline, attributed to enhanced gross margin management and tighter control of selling, general and administrative expenses. Gross profit margin improved to 10.4% from prior period levels, while SG&A expenses were controlled at 20.4B yen representing 7.8% of sales. By segment, Device Business operating profit increased to 4.1B yen from 3.0B yen (+35.5%), while Solution Business profit rose to 2.6B yen from 2.4B yen (+6.3%). The unallocated corporate costs decreased significantly to 0.1B yen from 0.3B yen, reflecting headquarters efficiency improvements.
Ordinary income grew 8.9B yen (+18.1%) to 5.8B yen, slightly trailing operating income growth due to net non-operating expenses of 0.9B yen. Non-operating items included foreign exchange losses and interest expenses, partially offset by dividend and equity method investment income. The non-operating expense ratio remained contained at approximately 1.3% of operating income.
Net income declined 26.1B yen (-32.1%) to 5.5B yen primarily due to a substantial decrease in extraordinary gains. In the prior period, the company recorded significant one-time gains from the business combination establishing the holding company structure, including goodwill recognition of 2.5B yen in Device Business and 0.6B yen in Solution Business. Current period extraordinary items included investment securities sales gains of 2.1B yen and total extraordinary income of 2.5B yen, offset by extraordinary losses of 0.2B yen including impairment losses. Income taxes amounted to 2.6B yen reflecting an effective tax rate of approximately 32%.
This represents a revenue down, profit up pattern, where top-line contraction was more than offset by operational efficiency improvements and margin expansion, though final net income was impacted by the absence of prior-year non-recurring gains from corporate restructuring.
The Device Business generated revenue of 187.0B yen and operating profit of 4.1B yen, representing operating margin of 2.2%. This segment accounts for 72% of total consolidated revenue and is the core business operation. Device Business profit increased 1.1B yen (+35.5% YoY) from 3.0B yen, demonstrating strong margin expansion despite a 6.7B yen revenue decline (-3.4%). The profit improvement reflects enhanced product mix optimization and cost structure refinement within semiconductor and electronic component distribution operations.
The Solution Business recorded revenue of 72.2B yen and operating profit of 2.6B yen, achieving operating margin of 3.5%. This segment contributes 28% of consolidated revenue and showed resilience with revenue growth of 0.3B yen (+0.4% YoY) and profit increase of 0.2B yen (+6.3%). The Solution Business maintains higher profitability margins compared to Device Business, indicating value-added service elements in system integration and IT solution provision.
Segment margin differential of 1.3 percentage points (Solution 3.5% vs Device 2.2%) highlights the structural profitability advantage of solution-oriented business models. Corporate costs allocated outside reportable segments decreased to 0.1B yen from 0.3B yen, representing improved headquarters cost efficiency following the holding company integration completed in April 2024.
[Profitability] Operating margin of 2.6% improved 0.4 percentage points from 2.2% in the prior year, reflecting enhanced cost management and favorable product mix despite revenue headwinds. Net profit margin of 2.1% declined 1.0 percentage points from 3.1% YoY due to the absence of prior-year extraordinary gains from corporate restructuring. ROE of 4.1% calculated via DuPont three-factor analysis (net profit margin 2.1% × asset turnover 1.08 × financial leverage 1.79) remains modest, constrained primarily by low net profitability. ROA stands at 2.3%, calculated as net income of 5.5B yen divided by average total assets of approximately 237B yen. [Cash Quality] Cash and deposits totaled 32.3B yen with short-term debt of 21.2B yen, yielding cash coverage of short-term borrowings at 1.52 times. Operating cash flow data is not disclosed in quarterly reporting, limiting assessment of cash earnings quality. Working capital efficiency shows room for improvement with receivables turnover at 141 days and inventory turnover at 88 days, both extended relative to industry medians. [Investment Efficiency] Total asset turnover of 1.08 times (annualized revenue of 345.6B yen divided by total assets of 241.0B yen) indicates moderate asset utilization. ROIC calculated at 3.6% (operating income after tax of 4.6B yen divided by invested capital of approximately 128B yen) remains subdued, reflecting low operating margins and capital intensity in working capital. [Financial Health] Equity ratio of 55.8% compares favorably to the holding company structure and provides financial stability cushion. Current ratio of 212.1% (current assets 203.6B yen divided by current liabilities 96.0B yen) and quick ratio of 153.5% demonstrate adequate short-term liquidity. Interest coverage ratio of 7.2 times (operating income 6.7B yen divided by interest expense 0.9B yen) indicates comfortable debt servicing capacity. Net cash position exists with cash exceeding total interest-bearing liabilities, though short-term liability composition warrants monitoring given 88.4% of total liabilities mature within one year.
Cash and deposits increased 2.9B yen from 29.4B yen to 32.3B yen, supported by operating profit growth to 6.7B yen. Working capital management shows mixed dynamics, with accounts receivable of 100.4B yen representing 141 days sales outstanding, extended from industry median of 79 days and indicating slower collection cycles. Inventory of 56.3B yen translates to 88 days on hand, also exceeding industry median of 56 days and suggesting inventory accumulation relative to sales velocity. Accounts payable stood at 64.9B yen, providing 107 days payable outstanding and representing a key financing source from supplier credit. The working capital cycle of 122 days (DSO 141 + inventory days 88 - DPO 107) remains lengthy and ties up substantial operating cash. Short-term borrowings decreased 9.5B yen from 30.7B yen to 21.2B yen, reflecting debt reduction efforts and improved liquidity positioning. Investment securities declined 2.6B yen due to portfolio sales generating 2.1B yen in extraordinary gains, converting illiquid holdings into cash. Short-term debt coverage by cash equivalents stands at 1.52 times, providing adequate buffer for refinancing requirements. The balance sheet structure shows 84.5% of assets in current form and 88.4% of liabilities in short-term maturity, creating potential duration mismatch risk despite net current asset surplus.
Ordinary income of 5.8B yen versus operating income of 6.7B yen indicates net non-operating expense of 0.9B yen, representing 1.3% of operating profit. Non-operating items comprise primarily interest expense of 0.9B yen, foreign exchange losses, and offsetting dividend income and equity method investment gains. The non-operating burden remains proportionally modest and does not materially distort core earnings. Extraordinary items significantly impacted reported net income, with extraordinary gains of 2.5B yen including investment securities sales gains of 2.1B yen, offset by extraordinary losses of 0.2B yen. These non-recurring items contributed approximately 2.3B yen net to pre-tax income, representing 28% of income before taxes of 8.1B yen. The reliance on investment portfolio monetization to bolster bottom-line results raises questions about core earnings sustainability. Operating cash flow disclosure is absent in quarterly reports, preventing direct comparison of net income to cash generation and limiting earnings quality assessment. However, the extended working capital cycle with DSO of 141 days and inventory days of 88 days suggests potential divergence between accrual earnings and cash realization. The current period absence of prior-year goodwill gains from the April 2024 holding company formation explains much of the net income decline, representing a normalization of earnings base.
Full-year guidance targets revenue of 370.0B yen, operating income of 9.5B yen, ordinary income of 8.0B yen, and net income of 6.0B yen. Through Q3 (9 months), progress rates stand at revenue 70.1%, operating income 70.7%, ordinary income 72.6%, and net income 92.0%. Against standard quarterly progression of 75% completion by Q3, revenue and operating income trail by approximately 5 percentage points, suggesting modest fourth quarter acceleration required. Net income progress of 92.0% substantially exceeds the standard pace, though this reflects the Q3 cumulative achievement relative to a conservative full-year target that anticipates normalized earnings without significant extraordinary gains. The implied fourth quarter requirements are revenue of 110.8B yen, operating income of 2.8B yen, ordinary income of 1.9B yen, and net income of 0.5B yen. Fourth quarter net income guidance of 0.5B yen appears conservative given Q3 year-to-date achievement of 5.5B yen. Management's full-year forecast assumes YoY changes of revenue +2.8%, operating income +11.2%, and ordinary income +12.1%, indicating expectations for full-year revenue recovery despite Q3 cumulative decline of 2.4%. The forecast-to-actual variance suggests potential conservatism in guidance or anticipated fourth quarter seasonal strength.
Annual dividend is planned at 140.0 yen per share, comprising interim dividend of 70.0 yen and year-end dividend of 70.0 yen. The dividend represents maintenance of the prior year level without increase. Based on full-year net income guidance of 6.0B yen and assuming approximately 40.06 million shares outstanding (derived from equity of 134.5B yen and book value considerations), the payout ratio calculates to approximately 93.6% against forecasted EPS of 149.75 yen. Using actual Q3 cumulative EPS basis of approximately 137.8 yen (5.5B yen net income divided by estimated shares), the trailing payout ratio stands at 101.5%. The calculated payout ratio of 136.9% cited in the analysis appears based on alternative share count assumptions, but all methods indicate elevated payout exceeding 90-100% of earnings. This high payout ratio raises sustainability concerns absent clear free cash flow coverage. No share buyback activity is disclosed in the current period. The total shareholder return consisting solely of dividends without capital distribution diversification concentrates payout policy risk on dividend maintenance. Given net cash balance sheet position (cash 32.3B yen exceeding interest-bearing debt of 24.0B yen) and equity base of 134.5B yen, the company maintains financial capacity to support dividends in the near term, though long-term sustainability depends critically on operating cash flow generation and earnings stability, neither of which is fully transparent from available quarterly disclosures.
Margin compression risk from low gross profitability of 10.4% leaves minimal buffer to absorb cost increases or pricing pressure. The Device Business concentration at 72% of revenue creates vulnerability to semiconductor cycle volatility and electronic component demand fluctuations. Operating leverage is limited with operating margin of only 2.6%, meaning relatively small revenue or gross margin changes materially impact bottom-line profitability.
Geographic concentration shift risk evidenced by China revenue decline of 22.7% to 66.3B yen indicates exposure to regional economic conditions and geopolitical factors. While Japan revenue increased to compensate, the 54.5% domestic concentration creates dependency on Japanese market conditions. Total Asia exposure including China remains approximately 42% of revenue, sustaining regional risk concentration.
Working capital management risk manifests in extended receivables at 141 days and inventory at 88 days, both substantially above industry medians. The 122-day cash conversion cycle ties up capital and creates potential cash flow stress if revenue contracts or collections slow further. Combined accounts receivable of 100.4B yen and inventory of 56.3B yen represent 65% of total assets, creating significant working capital intensity and collection risk exposure.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: ROE of 4.1% falls below the trading industry median of 6.4% (Q3 2025, IQR 2.4%-9.9%), positioning the company in the lower quartile for return on equity. Operating margin of 2.6% compares to industry median of 3.2% (IQR 1.7%-4.9%), indicating slightly below-median operational efficiency. Net profit margin of 2.1% aligns closely with industry median of 2.7% (IQR 1.3%-6.0%), though trending toward the lower range.
Financial Health: Equity ratio of 55.8% exceeds the industry median of 46.4% (IQR 39.6%-52.6%), demonstrating above-average financial stability and conservative capital structure. Current ratio of 2.12x compares favorably to industry median of 1.88x (IQR 1.64x-2.38x), indicating superior short-term liquidity positioning. Net debt to EBITDA is not meaningful given the company's net cash position, comparing favorably to industry median of -2.14 (indicating most peers also maintain net cash positions).
Efficiency: Asset turnover of 1.08x slightly exceeds industry median of 1.00x (IQR 0.62-1.20), suggesting marginally better asset utilization. However, working capital metrics lag substantially with receivables turnover at 141 days versus industry median of 79 days, and inventory turnover at 88 days versus median of 56 days. Operating working capital cycle substantially exceeds industry norms, indicating structural efficiency challenges. ROIC of 3.6% falls below the industry median of 4.0% (IQR 2.0%-13.0%), reflecting the combination of low margins and capital intensity.
Growth: Revenue decline of 2.4% contrasts with industry median growth of 5.0% (IQR -5.0% to +7.8%), positioning the company below median but within the interquartile range of industry performance. The growth underperformance primarily reflects China market contraction rather than broad-based weakness.
(Industry: Trading companies sector, N=19 companies for most metrics, Comparison: Q3 2025 fiscal period, Source: Proprietary analysis)
Operating profit growth of 16.8% despite revenue decline of 2.4% demonstrates successful margin expansion and cost discipline, with operating margin improving to 2.6% from 2.2%. This operating leverage improvement through the Device Business profit increase of 35.5% indicates management's ability to enhance profitability independent of top-line growth, representing a significant operational achievement within a challenging revenue environment.
Net income decline of 32.1% to 5.5B yen primarily reflects normalization from prior-year extraordinary gains related to the April 2024 holding company formation, rather than core earnings deterioration. Adjusting for the 2.1B yen current-period investment securities gains and prior-year business combination effects, underlying earnings show stability. However, the elevated payout ratio approaching 94-102% by various calculations creates dividend sustainability concerns requiring monitoring of free cash flow adequacy.
Working capital intensity with receivables at 141 days and inventory at 88 days, both substantially exceeding industry medians of 79 and 56 days respectively, represents a critical operational efficiency gap. The extended 122-day cash conversion cycle constrains cash generation and creates vulnerability to revenue volatility. Improvement in working capital velocity would materially enhance cash flow quality and support dividend sustainability, making receivables collection and inventory turnover key performance indicators to monitor in subsequent periods.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.